EU Drugs Regulator Studying Expanded Use of COVID-19 Drug Remdesivir
Tuesday, February 23, 2021 5:12 am |
< 1 Minute Read
Europe’s drugs regulator said on Tuesday it is evaluating the use of remdesivir in COVID-19 patients who do not need oxygen support, after developer Gilead Sciences submitted an application to extend the medicine’s use.
Europe had conditionally approved remdesivir, sold under the brand name Veklury, in July for treating COVID-19 in adults and adolescents with pneumonia requiring oxygen support.
To Read The Full Story
Are you already a subscriber?
Click "Sign In" to log in!
Become a Web Subscriber
Click “Subscribe” below to begin the process of becoming a new subscriber.
Become a Print + Web Subscriber
Click “Subscribe” below to begin the process of becoming a new subscriber.
Renew Print + Web Subscription
Click “Renew Subscription” below to begin the process of renewing your subscription.
